DUBLIN--(BUSINESS WIRE)--The "Flow Cytometry Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The global flow cytometry market grew at a CAGR of around 8% during 2014-2019. Looking forward, the publisher expects the global flow cytometry market to continue its moderate growth during the next five years.
Flow cytometry refers to a biophysical and laser-based analytical technology that is used in the analysis of the cells or micelles that are usually suspended in a fluid using a laser beam.
This technique aids in subclassifying cell types and detecting residual levels of disease through probes to develop the best treatment plan for the patient. Fluorescent probes, such as bisoxonol, can bind to proteins present on the cell membrane to facilitate the identification of various stages of cell injuries or necrosis. This technique also aids in understanding the structure and composition of the cells for chromosome analysis, cancer diagnosis, protein expression and diagnosis of diseases and hematological malignancies.
The increasing prevalence of chronic medical ailments, such as HIV-AIDS and cancer, is one of the key factors driving the growth of the market. The diagnosis of these diseases requires toxicity testing and an accurate, rapid and sensitive prognosis technique, which, in turn, is creating a positive outlook for the market growth. Furthermore, the widespread adoption of stem cell therapy is also enhancing the utilization of flow cytometry. Rising awareness regarding the benefits of this technique in immunophenotyping, cell sorting, cell proliferation assays and intracellular calcium flux is acting as another major growth-inducing factor.
Additionally, several technological advancements, such as the integration of flow cytometry devices with artificial intelligence (AI) platforms, along with the advent of advanced methods, are also contributing to the market growth. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market further.
Companies Mentioned
- Agilent Technologies Inc.
- Apogee Flow Systems Ltd.
- BD (Becton, Dickinson and Company)
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-RAD Laboratories Inc.
- Enzo Life Sciences Inc.
- Luminex Corporation
- Merck KGaA
- Sony Biotechnology Inc.
- Sysmex Partec GmbH
- Thermo Fisher Scientific Inc.
ey Questions Answered in This Report:
- How has the global flow cytometry market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global flow cytometry market?
- What is the breakup of the market based on the product and service?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global flow cytometry market and who are the key players?
- What is the degree of competition in the industry?
Key Topics Covered:
1 Preface
2 Scope and Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Flow Cytometry Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product and Service
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Reagents and Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Accessories
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Software
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Services
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Technology
7.1 Cell-Based Flow Cytometry
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Bead-Based Flow Cytometry
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Oncology
8.2 Drug Discovery
8.3 Disease Diagnosis
8.4 Stem Cell Therapy
8.5 Organ Transplantation
8.6 Hematology
8.7 Others
9 Market Breakup by End-User
9.1 Hospitals and Clinics
9.2 Academic and Research Institutes
9.3 Pharmaceutical and Biotechnology Companies
9.4 Others
10 Market Breakup by Region
10.1 North America
10.2 Asia Pacific
10.3 Europe
10.4 Latin America
10.5 Middle East and Africa
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
For more information about this report visit https://www.researchandmarkets.com/r/p0l2yw
